Has Aneesh Singla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $167,282 in general payments to Aneesh Singla, MD across 300 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aneesh Singla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aneesh Singla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aneesh Singla, MD

Interventional Pain Medicine · Salisbury, MDNPI 1205826377

Payments from drug & device makers

What this record shows

This record is dominated by other: $157,500 of the $167,282 with a category attached, or 94.2%. Curonix LLC accounts for 94.2% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2022 at $159,302 and has fallen 99.1% since, to $1,501 in 2025. Among interventional pain medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$167,282in general payments, 2019–2025

Across 300 payments — averaging $557.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Curonix LLC$158K
Medtronic$2K
Abbott$2K
Boston Scientific$1K
Stryker$1K
Collegium Pharmaceutical, Inc.$606
plus $3K from 34 others

What the payments were for

Travel & lodging$1,2891%
Food & beverage$8,4775%
Education$160%
Other$157,50094%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Curonix LLC	3	$157,535
Medtronic(2 entities)	54	$1,939
Abbott	44	$1,717
Boston Scientific	40	$1,205
Stryker	12	$1,059
Collegium Pharmaceutical, Inc.	36	$606
Vertos Medical, Inc.	9	$380
Nevro Corp.	8	$377
Relievant Medsystems, Inc.	9	$340
Spinal Simplicity, LLC	2	$306
Pfizer	10	$160
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	11	$151
Globus Medical	5	$146
Stimwave Technologies Incorporated	3	$145
Biotronik NRO, Inc.	3	$114
Scilex Pharmaceuticals Inc.	6	$114
GRT US Holding, Inc.	5	$112
Pacira Therapeutics, Inc.	1	$89
Averitas Pharma Inc.	3	$87
Fidia Pharma USA Inc.	4	$69
Nalu Medical, Inc.	1	$65
Vertex	3	$65
Biodelivery Sciences International, Inc.	3	$47
IBSA Pharma Inc.	2	$47
Pacira Pharmaceuticals Incorporated	2	$43
Redhill Biopharma Inc.	2	$38
Si-bone, Inc.	1	$35
Kaleo, Inc.	2	$33
Pernix Therapeutics Holdings, Inc.	2	$32
Lilly USA, LLC	2	$30
AbbVie(2 entities)	2	$30
SPR Therapeutics, Inc	1	$28
Johnson & Johnson	2	$24
Mallinckrodt Hospital Products Inc.	1	$21
Almatica Pharma LLC	1	$19
Baudax Bio Inc.	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$15
International Rehabilitative Sciences, Inc	1	$14
Electronic Waveform Lab, Inc.	1	$14
Amgen	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$167,282 in reported general payments places this provider in the 90th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$117,093

Medicare patients

235

Services billed

1,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	84	$1,027
Lidocaine	13	$982
Pregabalin	12	$190
Methylprednisolone	24	$175
Oxycodone Hcl	23	$165
Tramadol Hcl	25	$151
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$74
Meloxicam	13	$20
Diazepam	12	$10

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Salisbury

Ajit ShresthaSalisbury$3K
Parth PatelSalisbury$3K
Mark ColemanPikesville$1.3M
Marc LoevRockville$318K
Anish PatelFrederick$311K
Charles SimmonsAnnapolis$62K
Ali El-MohandesHagerstown$57K
Michael WongBel Air$31K
Anna IrwinBethesda$30K
Dontese NicholsonBaltimore$27K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →